US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2019-10-30T00:00:00
Nubeqa Tablets, imported in 300 mg tablet form, is a medicinal preparation containing, Darolutamide, as the active ingredient. It is indicated for the treatment of patients with non-metastic castration resistant prostate cancer (nmCRPC). Nubeqa is also used to treat men with prostate cancer that has not spread to other parts of the body and who no longer respond to a medical or surgical treatment that lowers testosterone.
Description : Darolutamide in bulk form and Nubeqa® Tablets in dosage form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :